368 related articles for article (PubMed ID: 14593165)
41. Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease.
Johnston JA; Liu WW; Todd SA; Coulson DT; Murphy S; Irvine GB; Passmore AP
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1096-100. PubMed ID: 16246054
[TBL] [Abstract][Full Text] [Related]
42. [Alzheimer's disease].
Yamazaki T
Tanpakushitsu Kakusan Koso; 1997 Oct; 42(14 Suppl):2393-8. PubMed ID: 9366224
[No Abstract] [Full Text] [Related]
43. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
44. sorLA: sorting out APP.
Shah S; Yu G
Mol Interv; 2006 Apr; 6(2):74-6, 58. PubMed ID: 16565469
[TBL] [Abstract][Full Text] [Related]
45. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
46. Pathogenic mechanisms in Alzheimer's disease.
Pastorino L; Lu KP
Eur J Pharmacol; 2006 Sep; 545(1):29-38. PubMed ID: 16904664
[TBL] [Abstract][Full Text] [Related]
47. Amyloid-beta precursor protein processing in neurodegeneration.
Wilquet V; De Strooper B
Curr Opin Neurobiol; 2004 Oct; 14(5):582-8. PubMed ID: 15464891
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
[TBL] [Abstract][Full Text] [Related]
49. Biochemistry. Intramembrane proteases--mixing oil and water.
Wolfe MS; Selkoe DJ
Science; 2002 Jun; 296(5576):2156-7. PubMed ID: 12077393
[No Abstract] [Full Text] [Related]
50. Assembly and activation of the gamma-secretase complex: roles of presenilin cofactors.
Iwatsubo T
Mol Psychiatry; 2004 Jan; 9(1):8-10. PubMed ID: 14581930
[No Abstract] [Full Text] [Related]
51. Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.
Debatin L; Streffer J; Geissen M; Matschke J; Aguzzi A; Glatzel M
Neurodegener Dis; 2008; 5(6):347-54. PubMed ID: 18349519
[TBL] [Abstract][Full Text] [Related]
52. A molecular approach to Alzheimer's disease.
Multhaup G; Masters CL; Beyreuther K
Biol Chem Hoppe Seyler; 1993 Jan; 374(1):1-8. PubMed ID: 8439394
[No Abstract] [Full Text] [Related]
53. Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration.
Rozemuller AJ; Jansen C; Carrano A; van Haastert ES; Hondius D; van der Vies SM; Hoozemans JJ
Neurodegener Dis; 2012; 10(1-4):301-4. PubMed ID: 22398730
[TBL] [Abstract][Full Text] [Related]
54. Roles of endoproteolytic α-cleavage and shedding of the prion protein in neurodegeneration.
Altmeppen HC; Prox J; Puig B; Dohler F; Falker C; Krasemann S; Glatzel M
FEBS J; 2013 Sep; 280(18):4338-47. PubMed ID: 23413979
[TBL] [Abstract][Full Text] [Related]
55. The P's and Q's of cellular PrP-Aβ interactions.
Westaway D; Jhamandas JH
Prion; 2012; 6(4):359-63. PubMed ID: 22874673
[TBL] [Abstract][Full Text] [Related]
56. [Proteins of Alzheimer's disease].
Piekiełko A
Postepy Biochem; 1999; 45(2):116-22. PubMed ID: 10581635
[No Abstract] [Full Text] [Related]
57. Distribution of intraneuronal immunoreactivity for the prion protein in human prion diseases.
Kovacs GG; Voigtländer T; Hainfellner JA; Budka H
Acta Neuropathol; 2002 Sep; 104(3):320-6. PubMed ID: 12172919
[TBL] [Abstract][Full Text] [Related]
58. Neurometals in the Pathogenesis of Prion Diseases.
Kawahara M; Kato-Negishi M; Tanaka KI
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
[TBL] [Abstract][Full Text] [Related]
59. Folding and misfolding of the prion protein in the secretory pathway.
Tatzelt J; Winklhofer KF
Amyloid; 2004 Sep; 11(3):162-72. PubMed ID: 15523918
[TBL] [Abstract][Full Text] [Related]
60. Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators.
Checler F; Vincent B
Trends Neurosci; 2002 Dec; 25(12):616-20. PubMed ID: 12446128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
